Published: 5 March 2020

Publications

Quarterly summary of recent safety communications

Prescriber Update 41(1): 12
March 2020

The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.

Date Communication Topic
23/01/2020 Monitoring Update – Everet (levetiracetam) - supply and potential seizure control issues for patients
23/01/2020 Monitoring Update – Dolutegravir and the possible risk of neural tube defects when taken early in pregnancy
21/01/2020 Dear Healthcare Professional Letter Gardasil 9 – Issue with 'tear-off' labels for Gardasil 9 vaccine (PDF 43 KB, 1 page)
14/01/2020 Dear Healthcare Professional Letter Accuretic – Supply in alternative (Canadian) artwork to New Zealand (PDF 490 KB, 2 pages)
08/01/2020 Monitoring M2 Logo Update – Risk of infections with Prolia (denosumab)
08/01/2020 Monitoring M2 Logo Update – Tramadol and opioid effects in breastfeeding babies
20/12/2019 Monitoring Update on suspected adverse reaction reports to lamotrigine after changing brands
19/12/2019 Alert EpiPen® Jr 150 mcg Adrenaline (epinephrine) Auto-Injector containing trace levels of Pralidoxime
17/12/2019 Dear Healthcare Professional Letter Tivicay and dolutegravir containing regimens – updated information (PDF 134 KB, 2 pages )
9/12/2019 Monitoring M2 Logo Update – Isotretinoin and Obsessive Compulsive Disorder (OCD)
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /